Status:
COMPLETED
RHODOS Follow-up Single-visit Study
Lead Sponsor:
Santhera Pharmaceuticals
Conditions:
Leber's Hereditary Optic Neuropathy
Eligibility:
All Genders
15-69 years
Brief Summary
This study aims to evaluate the current visual acuity of SNT-II-003 participants and compare this with the last visit from the SNT-II-003 study.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Previous participation in study SNT-II-003
Exclusion
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01421381
Start Date
September 1 2011
End Date
December 1 2011
Last Update
May 27 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Notre-Dame (CHUM)
Montreal, Quebec, Canada, H2L 4M1
2
Friedrich Baur Institut Neurologische Klinik und Poliklinik
München, Germany, D-80336
3
Biomedical Research Centre, The Medical School
Newcastle upon Tyne, United Kingdom, NE2 4HH